Nutritional supplements in age-related macular degeneration

Doreen Schmidl, Gerhard Garhöfer*, Leopold Schmetterer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

38 Citations (Scopus)

Abstract

Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. While with new therapies that are directed towards vascular endothelial growth factor (VEGF), a potentially efficient treatment option for the wet form of the disease has been introduced, a therapeutic regimen for dry AMD is still lacking. There is evidence from several studies that oral intake of supplements is beneficial in preventing progression of the disease. Several formulations of micronutrients are currently available. The present review focuses on the role of supplements in the treatment and prevention of AMD and sums up the current knowledge about the most frequently used micronutrients. In addition, regulatory issues are discussed, and future directions for the role of supplementation in AMD are highlighted.

Original languageEnglish
Pages (from-to)105-121
Number of pages17
JournalActa Ophthalmologica
Volume93
Issue number2
DOIs
Publication statusPublished - Mar 1 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • Age-Related Eye Disease Study
  • age-related macular degeneration
  • lutein
  • reactive oxygen intermediates
  • supplementation
  • vitamins
  • zeaxanthin
  • zinc

Fingerprint

Dive into the research topics of 'Nutritional supplements in age-related macular degeneration'. Together they form a unique fingerprint.

Cite this